{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:48:50Z","timestamp":1790203730885,"version":"4.1.0"},"reference-count":117,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372578"],"award-info":[{"award-number":["82372578"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Youth Science and Technology Sail Project","award":["23YF1444000"],"award-info":[{"award-number":["23YF1444000"]}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission\u20132023 Shanghai College Young Teacher Training Funding Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002397","name":"shanghai university of sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Neuroscientist"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>\n                    Neuropathic pain (NP) is a chronic pain condition caused by nerve damage. Current NP treatments have limited efficacy and significant side effects. Emerging evidence demonstrates that\n                    <jats:italic toggle=\"yes\">N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d<\/jats:sc>\n                    -aspartate receptors (NMDARs) play a key role in the development of NP, especially in their pre- and postsynaptic functions. This review provides an overview of the mechanistic roles of NMDARs in NP, focusing on their subunit structures and involvement in pain transmission. The interactions between NMDARs and other neurotransmitter receptors are further discussed, emphasizing NMDARs as a promising therapeutic target. Finally, we discuss the pharmacologic mechanisms of NMDARs relevant to pain management and nonpharmacologic interventions, which have not been covered in previous reviews. This review aims to advance future research on NMDAR-mediated mechanisms in NP and promote the development of targeted, low\u2013side effect therapeutic strategies.\n                  <\/jats:p>","DOI":"10.1177\/10738584251410528","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:18:24Z","timestamp":1769505504000},"page":"126-142","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["NMDA Receptors in Neuropathic Pain: From Mechanisms to Therapeutic Strategies"],"prefix":"10.1177","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1804-2628","authenticated-orcid":false,"given":"Xi-Yue","family":"Li","sequence":"first","affiliation":[{"name":"Department of Sport Rehabilitation, Shanghai University of Sport, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9340-2808","authenticated-orcid":false,"given":"Zhi-Min","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Sport Rehabilitation, Shanghai University of Sport, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3756-9490","authenticated-orcid":false,"given":"Sheng-Jie","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Sport Rehabilitation, Shanghai University of Sport, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4523-560X","authenticated-orcid":false,"given":"Lu-Ning","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Sport Rehabilitation, Shanghai University of Sport, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0494-8702","authenticated-orcid":false,"given":"Ting","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Sport Rehabilitation, Shanghai University of Sport, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6013-2801","authenticated-orcid":false,"given":"Jia-Lu","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Sport Rehabilitation, Shanghai University of Sport, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3154-9568","authenticated-orcid":false,"given":"Yi-Li","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Sport Rehabilitation, Shanghai University of Sport, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"crossref","unstructured":"Abbott JA et al. 2025. Allosteric inhibition of NMDA receptors by low dose ketamine. Mol Psychiatry. 30(3):1009\u20131018. https:\/\/doi.org\/10.1038\/s41380-024-02729-9","DOI":"10.1038\/s41380-024-02729-9"},{"key":"e_1_3_3_3_1","doi-asserted-by":"crossref","unstructured":"Alfaro-Rodriguez A et al. 2024. Association of the serotonin and kynurenine pathways as possible therapeutic targets to modulate pain in patients with fibromyalgia. Pharmaceuticals (Basel). 17(9). https:\/\/doi.org\/10.3390\/ph17091205","DOI":"10.3390\/ph17091205"},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","unstructured":"Altier C Zamponi GW. 2008. Signaling complexes of voltage-gated calcium channels and G protein\u2013coupled receptors. J Recept Signal Transduct Res. 28(1\u20132):71\u201381. https:\/\/doi.org\/10.1080\/10799890801941947","DOI":"10.1080\/10799890801941947"},{"key":"e_1_3_3_5_1","doi-asserted-by":"crossref","unstructured":"Bai HP et al. 2014. Activation of spinal GABAB receptors normalizes N-methyl-d-aspartate receptor in diabetic neuropathy. J Neurol Sci. 341(1\u20132):68\u201372. https:\/\/doi.org\/10.1016\/j.jns.2014.04.002","DOI":"10.1016\/j.jns.2014.04.002"},{"key":"e_1_3_3_6_1","doi-asserted-by":"crossref","unstructured":"Beedle AM et al. 2004. Agonist-independent modulation of N-type calcium channels by ORL1 receptors. Nat Neurosci. 7(2):118\u2013125. https:\/\/doi.org\/10.1038\/nn1180","DOI":"10.1038\/nn1180"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-67148-7_1"},{"key":"e_1_3_3_8_1","doi-asserted-by":"crossref","unstructured":"Berry JN et al. 2016. Corticosterone enhances N-methyl-d-aspartate receptor signaling to promote isolated ventral tegmental area activity in a reconstituted mesolimbic dopamine pathway. Brain Res Bull. 120:159\u2013165. https:\/\/doi.org\/10.1016\/j.brainresbull.2015.11.018","DOI":"10.1016\/j.brainresbull.2015.11.018"},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","unstructured":"Bossi S Pizzamiglio L Paoletti P. 2023. Excitatory GluN1\/GluN3A glycine receptors (eGlyRs) in brain signaling. Trends Neurosci. 46(8):667\u2013681. https:\/\/doi.org\/10.1016\/j.tins.2023.05.002","DOI":"10.1016\/j.tins.2023.05.002"},{"key":"e_1_3_3_10_1","doi-asserted-by":"crossref","unstructured":"Bouhassira D. 2019. Neuropathic pain: definition assessment and epidemiology. Rev Neurol (Paris). 175(1\u20132):16\u201325. https:\/\/doi.org\/10.1016\/j.neurol.2018.09.016","DOI":"10.1016\/j.neurol.2018.09.016"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","unstructured":"Brifault C et al. 2020. Deletion of the gene encoding the NMDA receptor GluN1 subunit in Schwann cells causes ultrastructural changes in remak bundles and hypersensitivity in pain processing. J Neurosci. 40(47):9121\u20139136. https:\/\/doi.org\/10.1523\/JNEUROSCI.0663-20.2020","DOI":"10.1523\/JNEUROSCI.0663-20.2020"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","unstructured":"Camp CR et al. 2023. Loss of Grin2a causes a transient delay in the electrophysiological maturation of hippocampal parvalbumin interneurons. Commun Biol. 6(1):952. https:\/\/doi.org\/10.1038\/s42003-023-05298-9","DOI":"10.1038\/s42003-023-05298-9"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","unstructured":"Candelas Serra M et al. 2024. Characterization of mice carrying a neurodevelopmental disease-associated GluN2B(L825V) variant. J Neurosci. 44(31). https:\/\/doi.org\/10.1523\/JNEUROSCI.2291-23.2024","DOI":"10.1523\/JNEUROSCI.2291-23.2024"},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","unstructured":"Cao B et al. 2024. Pathology of pain and its implications for therapeutic interventions. Signal Transduct Target Ther. 9(1):155. https:\/\/doi.org\/10.1038\/s41392-024-01845-w","DOI":"10.1038\/s41392-024-01845-w"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","unstructured":"Chen QY et al. 2021. NMDA GluN2C\/2D receptors contribute to synaptic regulation and plasticity in the anterior cingulate cortex of adult mice. Mol Brain. 14(1):60. https:\/\/doi.org\/10.1186\/s13041-021-00744-3","DOI":"10.1186\/s13041-021-00744-3"},{"key":"e_1_3_3_16_1","doi-asserted-by":"crossref","unstructured":"Chen SR Chen H Jin D Pan HL. 2022. Brief opioid exposure paradoxically augments primary afferent input to spinal excitatory neurons via alpha2delta-1-dependent presynaptic NMDA receptors. J Neurosci. 42(50):9315\u20139329. https:\/\/doi.org\/10.1523\/JNEUROSCI.1704-22.2022","DOI":"10.1523\/JNEUROSCI.1704-22.2022"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","unstructured":"Choi SR et al. 2017. Spinal d-serine increases PKC-dependent GluN1 phosphorylation contributing to the sigma-1 receptor-induced development of mechanical allodynia in a mouse model of neuropathic pain. J Pain. 18(4):415\u2013427. https:\/\/doi.org\/10.1016\/j.jpain.2016.12.002","DOI":"10.1016\/j.jpain.2016.12.002"},{"key":"e_1_3_3_18_1","doi-asserted-by":"crossref","unstructured":"Chou TH et al. 2022a. Structural insights into binding of therapeutic channel blockers in NMDA receptors. Nat Struct Mol Biol. 29(6):507\u2013518. https:\/\/doi.org\/10.1038\/s41594-022-00772-0","DOI":"10.1038\/s41594-022-00772-0"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","unstructured":"Chou TH Kang H Simorowski N Traynelis SF Furukawa H. 2022b. Structural insights into assembly and function of GluN1-2C GluN1-2A-2C and GluN1-2D NMDARs. Mol Cell. 82(23):4548\u20134563 e4544. https:\/\/doi.org\/10.1016\/j.molcel.2022.10.008","DOI":"10.1016\/j.molcel.2022.10.008"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","unstructured":"Corlew R Brasier DJ Feldman DE Philpot BD. 2008. Presynaptic NMDA receptors: newly appreciated roles in cortical synaptic function and plasticity. Neuroscientist. 14(6):609\u2013625. https:\/\/doi.org\/10.1177\/1073858408322675","DOI":"10.1177\/1073858408322675"},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","unstructured":"Cortes-Montero E et al. 2020. Calmodulin supports TRPA1 channel association with opioid receptors and glutamate NMDA receptors in the nervous tissue. Int J Mol Sci. 22(1). https:\/\/doi.org\/10.3390\/ijms22010229","DOI":"10.3390\/ijms22010229"},{"key":"e_1_3_3_22_1","doi-asserted-by":"crossref","unstructured":"Corti E Duarte CB. 2023. The role of post-translational modifications in synaptic AMPA receptor activity. Biochem Soc Trans. 51(1):315\u2013330. https:\/\/doi.org\/10.1042\/BST20220827","DOI":"10.1042\/BST20220827"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","unstructured":"Cruccu G Truini A. 2017. A review of neuropathic pain: from guidelines to clinical practice. Pain Ther. 6(suppl 1):35\u201342. https:\/\/doi.org\/10.1007\/s40122-017-0087-0","DOI":"10.1007\/s40122-017-0087-0"},{"key":"e_1_3_3_24_1","doi-asserted-by":"crossref","unstructured":"Czarnecka K Chuchmacz J Wojtowicz P Szymanski P. 2021. Memantine in neurological disorders\u2014schizophrenia and depression. J Mol Med (Berl). 99(3):327\u2013334. https:\/\/doi.org\/10.1007\/s00109-020-01982-z","DOI":"10.1007\/s00109-020-01982-z"},{"key":"e_1_3_3_25_1","doi-asserted-by":"crossref","unstructured":"Dalmau-Roig A et al. 2025. A multidisciplinary pain management program for patients with chronic low back pain: a randomized single-blind controlled feasibility study. BMC Musculoskelet Disord. 26(1):59. https:\/\/doi.org\/10.1186\/s12891-025-08294-8","DOI":"10.1186\/s12891-025-08294-8"},{"key":"e_1_3_3_26_1","doi-asserted-by":"crossref","unstructured":"de Leon-Lopez CAM Carretero-Rey M Khan ZU. 2025. AMPA receptors in synaptic plasticity memory function and brain diseases. Cell Mol Neurobiol. 45(1):14. https:\/\/doi.org\/10.1007\/s10571-024-01529-7","DOI":"10.1007\/s10571-024-01529-7"},{"key":"e_1_3_3_27_1","doi-asserted-by":"crossref","unstructured":"Deng M Chen SR Pan HL. 2019. Presynaptic NMDA receptors control nociceptive transmission at the spinal cord level in neuropathic pain. Cell Mol Life Sci. 76(10):1889\u20131899. https:\/\/doi.org\/10.1007\/s00018-019-03047-y","DOI":"10.1007\/s00018-019-03047-y"},{"key":"e_1_3_3_28_1","doi-asserted-by":"crossref","unstructured":"Drotos AC Zarb RL Booth V Roberts MT. 2024. GluN2C\/D-containing NMDA receptors enhance temporal summation and increase sound-evoked and spontaneous firing in the inferior colliculus. J Physiol. 603:6319\u20136343. https:\/\/doi.org\/10.1113\/JP286754","DOI":"10.1113\/JP286754"},{"key":"e_1_3_3_29_1","doi-asserted-by":"crossref","unstructured":"Egunlusi AO Joubert J. 2024. NMDA receptor antagonists: emerging insights into molecular mechanisms and clinical applications in neurological disorders. Pharmaceuticals (Basel). 17(5). https:\/\/doi.org\/10.3390\/ph17050639","DOI":"10.3390\/ph17050639"},{"key":"e_1_3_3_30_1","doi-asserted-by":"crossref","unstructured":"Eller-Smith OC Nicol AL Christianson JA. 2018. Potential mechanisms underlying centralized pain and emerging therapeutic interventions. Front Cell Neurosci. 12:35. https:\/\/doi.org\/10.3389\/fncel.2018.00035","DOI":"10.3389\/fncel.2018.00035"},{"key":"e_1_3_3_31_1","doi-asserted-by":"crossref","unstructured":"Gakare SG Shelkar GP Gawande DY Pavuluri R Gandhi PJ Dravid SM. 2024. GluN2D-containing NMDA receptors in parvalbumin neurons in the nucleus accumbens regulate nocifensive responses in neuropathic pain. Neurobiol Dis. 205:106784. https:\/\/doi.org\/10.1016\/j.nbd.2024.106784","DOI":"10.1016\/j.nbd.2024.106784"},{"key":"e_1_3_3_32_1","doi-asserted-by":"crossref","unstructured":"Geoffroy C et al. 2024. Reversible control of native GluN2B-containing NMDA receptors with visible light. ACS Chemical Neuroscience. 15(18):3321\u20133343. https:\/\/doi.org\/10.1021\/acschemneuro.4c00247","DOI":"10.1021\/acschemneuro.4c00247"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","unstructured":"Ghovanloo M-R Tyagi S Zhao P Waxman SG. 2025. Nav1.8 an analgesic target for nonpsychotomimetic phytocannabinoids. Proc Natl Acad Sci U S A. 122(4):e2416886122. https:\/\/doi.org\/10.1073\/pnas.2416886122","DOI":"10.1073\/pnas.2416886122"},{"key":"e_1_3_3_34_1","doi-asserted-by":"crossref","unstructured":"Grand T Abi Gerges S David M Diana MA Paoletti P. 2018. Unmasking GluN1\/GluN3A excitatory glycine NMDA receptors. Nat Commun. 9(1):4769. https:\/\/doi.org\/10.1038\/s41467-018-07236-4","DOI":"10.1038\/s41467-018-07236-4"},{"key":"e_1_3_3_35_1","doi-asserted-by":"crossref","unstructured":"Guo Q. 2025. Quantitative analysis of the interaction between NMDA and AMPA receptors in glutamatergic synapses based on mathematical model. Neurosci Res. 212:127\u2013135. https:\/\/doi.org\/10.1016\/j.neures.2024.10.003","DOI":"10.1016\/j.neures.2024.10.003"},{"key":"e_1_3_3_36_1","doi-asserted-by":"crossref","unstructured":"Guo SJ Shi YQ Zheng YN Liu H Zheng YL. 2025. The voltage-gated calcium channel alpha2delta subunit in neuropathic pain. Mol Neurobiol. 62(2):2561\u20132572. https:\/\/doi.org\/10.1007\/s12035-024-04424-w","DOI":"10.1007\/s12035-024-04424-w"},{"key":"e_1_3_3_37_1","doi-asserted-by":"crossref","unstructured":"He YT et al. 2019. A synthetic peptide disturbing GluN2A\/SHP1 interaction in dorsal root ganglion attenuated pathological pain. Eur J Pharmacol. 854:62\u201369. https:\/\/doi.org\/10.1016\/j.ejphar.2019.03.060","DOI":"10.1016\/j.ejphar.2019.03.060"},{"key":"e_1_3_3_38_1","doi-asserted-by":"crossref","unstructured":"Henson MA Roberts AC Perez-Otano I Philpot BD. 2010. Influence of the NR3A subunit on NMDA receptor functions. Prog Neurobiol. 91(1):23\u201337. https:\/\/doi.org\/10.1016\/j.pneurobio.2010.01.004","DOI":"10.1016\/j.pneurobio.2010.01.004"},{"key":"e_1_3_3_39_1","doi-asserted-by":"crossref","unstructured":"Huang X et al. 2025. Structural insights into the diverse actions of magnesium on NMDA receptors. Neuron. 113(7):1006\u20131018 e1004. https:\/\/doi.org\/10.1016\/j.neuron.2025.01.021","DOI":"10.1016\/j.neuron.2025.01.021"},{"key":"e_1_3_3_40_1","doi-asserted-by":"crossref","unstructured":"Huang Y Chen H Chen S-R Pan H-L. 2025a. Tonic GABA and glycine inhibition control pain hypersensitivity via limiting \u03b12\u03b4-1- and mGluR5-dependent NMDA receptor activity at primary afferent\u2013excitatory neuron synapses. J Neurosci. 45:e1469252025. https:\/\/doi.org\/10.1523\/JNEUROSCI.1469-25.2025","DOI":"10.1523\/JNEUROSCI.1469-25.2025"},{"key":"e_1_3_3_41_1","doi-asserted-by":"crossref","unstructured":"Huang Y Chen SR Pan HL. 2025b. \u03b12\u03b4\u20131\u2013Linked NMDA and AMPA receptors in neuropathic pain and gabapentinoid action. J Neurochem. 169(4):e70064. https:\/\/doi.org\/10.1111\/jnc.70064","DOI":"10.1111\/jnc.70064"},{"key":"e_1_3_3_42_1","doi-asserted-by":"crossref","unstructured":"Huang Y et al. 2025c. Emerging roles of GluN3B NMDA receptor subunit in the central nervous system. Neurosci Bull. https:\/\/doi.org\/10.1007\/s12264-025-01523-z","DOI":"10.1007\/s12264-025-01523-z"},{"key":"e_1_3_3_43_1","doi-asserted-by":"crossref","unstructured":"Jafarzadeh E et al. 2023. Management of diabetic neuropathy with memantine: a randomized clinical trial. Diab Vasc Dis Res. 20(4):14791641231191093. https:\/\/doi.org\/10.1177\/14791641231191093","DOI":"10.1177\/14791641231191093"},{"key":"e_1_3_3_44_1","doi-asserted-by":"crossref","unstructured":"Jiang Y Xu HE. 2020. GABA(B) receptor pas de deux: insights from high-resolution structures. Cell Res. 30(8):631\u2013632. https:\/\/doi.org\/10.1038\/s41422-020-0373-y","DOI":"10.1038\/s41422-020-0373-y"},{"key":"e_1_3_3_45_1","doi-asserted-by":"crossref","unstructured":"Jie S Fu A Wang C Rajabi S. 2025. A comprehensive review on the impact of polyphenol supplementation and exercise on depression and brain function parameters. Behav Brain Funct. 21(1):10. https:\/\/doi.org\/10.1186\/s12993-025-00273-2","DOI":"10.1186\/s12993-025-00273-2"},{"key":"e_1_3_3_46_1","doi-asserted-by":"crossref","unstructured":"Jin D et al. 2023. mGluR5 from primary sensory neurons promotes opioid-induced hyperalgesia and tolerance by interacting with and potentiating synaptic NMDA receptors. J Neurosci. 43(31):5593\u20135607. https:\/\/doi.org\/10.1523\/JNEUROSCI.0601-23.2023","DOI":"10.1523\/JNEUROSCI.0601-23.2023"},{"key":"e_1_3_3_47_1","doi-asserted-by":"crossref","unstructured":"Jozwiak-Bebenista M Sokolowska P Wiktorowska-Owczarek A Kowalczyk E Sienkiewicz M. 2024. Ketamine: a new antidepressant drug with anti-inflammatory properties. J Pharmacol Exp Ther. 388(1):134\u2013144. https:\/\/doi.org\/10.1124\/jpet.123.001823","DOI":"10.1124\/jpet.123.001823"},{"key":"e_1_3_3_48_1","doi-asserted-by":"crossref","unstructured":"Kankowski S Grothe C Haastert-Talini K. 2021. Neuropathic pain: spotlighting anatomy experimental models mechanisms and therapeutic aspects. Eur J Neurosci. 54(2):4475\u20134496. https:\/\/doi.org\/10.1111\/ejn.15266","DOI":"10.1111\/ejn.15266"},{"key":"e_1_3_3_49_1","doi-asserted-by":"crossref","unstructured":"Kim H Choi S Lee E Koh W Lee CJ. 2024. Tonic NMDA receptor currents in the brain: regulation and cognitive functions. Biol Psychiatry. 96(3):164\u2013175. https:\/\/doi.org\/10.1016\/j.biopsych.2024.03.009","DOI":"10.1016\/j.biopsych.2024.03.009"},{"key":"e_1_3_3_50_1","doi-asserted-by":"crossref","unstructured":"Kim HJ et al. 2025. GluN2B-mediated regulation of silent synapses for receptor specification and addiction memory. Exp Mol Med. 57:436\u2013449. https:\/\/doi.org\/10.1038\/s12276-025-01399-z","DOI":"10.1038\/s12276-025-01399-z"},{"key":"e_1_3_3_51_1","doi-asserted-by":"crossref","unstructured":"Ladagu AD Olopade FE Adejare A Olopade JO. 2023. GluN2A and GluN2B N-methyl-d-aspartate receptor (NMDARs) subunits: their roles and therapeutic antagonists in neurological diseases. Pharmaceuticals (Basel). 16(11):1535. https:\/\/doi.org\/10.3390\/ph16111535","DOI":"10.3390\/ph16111535"},{"key":"e_1_3_3_52_1","doi-asserted-by":"crossref","unstructured":"Laurie DJ Seeburg PH. 1994. Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA. J Neurosci. 14(5 pt 2):3180\u20133194. https:\/\/doi.org\/10.1523\/JNEUROSCI.14-05-03180.1994","DOI":"10.1523\/JNEUROSCI.14-05-03180.1994"},{"key":"e_1_3_3_53_1","doi-asserted-by":"crossref","unstructured":"Leo LM Abood ME. 2021. CB1 cannabinoid receptor signaling and biased signaling. Molecules. 26(17):5413. https:\/\/doi.org\/10.3390\/molecules26175413","DOI":"10.3390\/molecules26175413"},{"key":"e_1_3_3_54_1","doi-asserted-by":"crossref","unstructured":"Li L Chen J Li YQ. 2023. The downregulation of opioid receptors and neuropathic pain. Int J Mol Sci. 24(6):5981. https:\/\/doi.org\/10.3390\/ijms24065981","DOI":"10.3390\/ijms24065981"},{"key":"e_1_3_3_55_1","doi-asserted-by":"crossref","unstructured":"Li L et al. 2021. \u03b12\u03b4-1 Switches the phenotype of synaptic AMPA receptors by physically disrupting heteromeric subunit assembly. Cell Rep. 36(3):109396. https:\/\/doi.org\/10.1016\/j.celrep.2021.109396","DOI":"10.1016\/j.celrep.2021.109396"},{"key":"e_1_3_3_56_1","doi-asserted-by":"crossref","unstructured":"Liu QQ et al. 2020. Role of 5-HT receptors in neuropathic pain: potential therapeutic implications. Pharmacol Res. 159:104949. https:\/\/doi.org\/10.1016\/j.phrs.2020.104949","DOI":"10.1016\/j.phrs.2020.104949"},{"key":"e_1_3_3_57_1","doi-asserted-by":"crossref","unstructured":"Liu S et al. 2018. IL-18 contributes to bone cancer pain by regulating glia cells and neuron interaction. J Pain. 19(2):186\u2013195. https:\/\/doi.org\/10.1016\/j.jpain.2017.10.003","DOI":"10.1016\/j.jpain.2017.10.003"},{"key":"e_1_3_3_58_1","doi-asserted-by":"crossref","unstructured":"Liu S et al. 2021. Icaritin alleviates glutamate-induced neuronal damage by inactivating GluN2B-containing NMDARs through the ERK\/DAPK1 pathway. Front Neurosci. 15:525615. https:\/\/doi.org\/10.3389\/fnins.2021.525615","DOI":"10.3389\/fnins.2021.525615"},{"key":"e_1_3_3_59_1","doi-asserted-by":"crossref","unstructured":"Liu XJ Salter MW. 2010. Glutamate receptor phosphorylation and trafficking in pain plasticity in spinal cord dorsal horn. Eur J Neurosci. 32(2):278\u2013289. https:\/\/doi.org\/10.1111\/j.1460-9568.2010.07351.x","DOI":"10.1111\/j.1460-9568.2010.07351.x"},{"key":"e_1_3_3_60_1","doi-asserted-by":"crossref","unstructured":"Lu W et al. 2024. METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2. J Clin Invest. 134(6):e174847. https:\/\/doi.org\/10.1172\/JCI174847","DOI":"10.1172\/JCI174847"},{"key":"e_1_3_3_61_1","doi-asserted-by":"crossref","unstructured":"Ma S et al. 2023. Author correction: sustained antidepressant effect of ketamine through NMDAR trapping in the LHb. Nature. 623(7988):E11. https:\/\/doi.org\/10.1038\/s41586-023-06814-x","DOI":"10.1038\/s41586-023-06814-x"},{"key":"e_1_3_3_62_1","doi-asserted-by":"crossref","unstructured":"Maeda Y Lisi TL Vance CG Sluka KA. 2007. Release of GABA and activation of GABA(A) in the spinal cord mediates the effects of TENS in rats. Brain Res. 1136(1):43\u201350. https:\/\/doi.org\/10.1016\/j.brainres.2006.11.061","DOI":"10.1016\/j.brainres.2006.11.061"},{"key":"e_1_3_3_63_1","doi-asserted-by":"crossref","unstructured":"Magruder T et al. 2024. Ketamine: an imperfect wonder drug? Biochem Pharmacol. 229:116516. https:\/\/doi.org\/10.1016\/j.bcp.2024.116516","DOI":"10.1016\/j.bcp.2024.116516"},{"key":"e_1_3_3_64_1","doi-asserted-by":"crossref","unstructured":"Mangano GD et al. 2022. De novo GRIN2A variants associated with epilepsy and autism and literature review. Epilepsy Behav. 129:108604. https:\/\/doi.org\/10.1016\/j.yebeh.2022.108604","DOI":"10.1016\/j.yebeh.2022.108604"},{"key":"e_1_3_3_65_1","doi-asserted-by":"crossref","unstructured":"Martins DF Siteneski A Ludtke DD Dal-Secco D Santos ARS. 2017. High-intensity swimming exercise decreases glutamate-induced nociception by activation of G-protein\u2013coupled receptors inhibiting phosphorylated protein kinase A. Mol Neurobiol. 54(7):5620\u20135631. https:\/\/doi.org\/10.1007\/s12035-016-0095-9","DOI":"10.1007\/s12035-016-0095-9"},{"key":"e_1_3_3_66_1","doi-asserted-by":"crossref","unstructured":"Matsuno H et al. 2015. A naturally occurring null variant of the NMDA type glutamate receptor NR3B subunit is a risk factor of schizophrenia. PLoS One. 10(3):e0116319. https:\/\/doi.org\/10.1371\/journal.pone.0116319","DOI":"10.1371\/journal.pone.0116319"},{"key":"e_1_3_3_67_1","doi-asserted-by":"crossref","unstructured":"Michalski K Furukawa H. 2024. Structure and function of GluN1-3A NMDA receptor excitatory glycine receptor channel. Sci Adv. 10(15):eadl5952. https:\/\/doi.org\/10.1126\/sciadv.adl5952","DOI":"10.1126\/sciadv.adl5952"},{"key":"e_1_3_3_68_1","doi-asserted-by":"crossref","unstructured":"Mokhtari T Ren Q Li N Wang F Bi Y Hu L. 2020. Transcutaneous electrical nerve stimulation in relieving neuropathic pain: basic mechanisms and clinical applications. Curr Pain Headache Rep. 24(4):14. https:\/\/doi.org\/10.1007\/s11916-020-0846-1","DOI":"10.1007\/s11916-020-0846-1"},{"key":"e_1_3_3_69_1","doi-asserted-by":"crossref","unstructured":"Mony L Zhu S Carvalho S Paoletti P. 2011. Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines. EMBO J. 30(15):3134\u20133146. https:\/\/doi.org\/10.1038\/emboj.2011.203","DOI":"10.1038\/emboj.2011.203"},{"key":"e_1_3_3_70_1","doi-asserted-by":"crossref","unstructured":"Monyer H Burnashev N Laurie DJ Sakmann B Seeburg PH. 1994. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 12(3):529\u2013540. https:\/\/doi.org\/10.1016\/0896-6273(94)90210-0","DOI":"10.1016\/0896-6273(94)90210-0"},{"key":"e_1_3_3_71_1","doi-asserted-by":"crossref","unstructured":"Munawar N Bitar MS Masocha W. 2023. Activation of 5-HT1A receptors normalizes the overexpression of presynaptic 5-HT1A receptors and alleviates diabetic neuropathic pain. Int J Mol Sci. 24(18):14334. https:\/\/doi.org\/10.3390\/ijms241814334","DOI":"10.3390\/ijms241814334"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1017\/UPO9780987073051.012"},{"key":"e_1_3_3_73_1","doi-asserted-by":"crossref","unstructured":"Paoletti P. 2011. Molecular basis of NMDA receptor functional diversity. Eur J Neurosci. 33(8):1351\u20131365. https:\/\/doi.org\/10.1111\/j.1460-9568.2011.07628.x","DOI":"10.1111\/j.1460-9568.2011.07628.x"},{"key":"e_1_3_3_74_1","doi-asserted-by":"crossref","unstructured":"Paoletti P Bellone C Zhou Q. 2013. NMDA receptor subunit diversity: impact on receptor properties synaptic plasticity and disease. Nat Rev Neurosci. 14(6):383\u2013400. https:\/\/doi.org\/10.1038\/nrn3504","DOI":"10.1038\/nrn3504"},{"key":"e_1_3_3_75_1","doi-asserted-by":"crossref","unstructured":"Puscasu C Chirita C Negres S Blebea NM. 2024. Exploring the therapeutic potential of N-methyl-d-aspartate receptor antagonists in neuropathic pain management. Int J Mol Sci. 25(20):11111. https:\/\/doi.org\/10.3390\/ijms252011111","DOI":"10.3390\/ijms252011111"},{"key":"e_1_3_3_76_1","doi-asserted-by":"crossref","unstructured":"Qneibi M et al. 2024. AMPA receptor neurotransmission and therapeutic applications: a comprehensive review of their multifaceted modulation. Eur J Med Chem. 266:116151. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116151","DOI":"10.1016\/j.ejmech.2024.116151"},{"key":"e_1_3_3_77_1","doi-asserted-by":"crossref","unstructured":"Rey AA Purrio M Viveros MP Lutz B. 2012. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology. 37(12):2624\u20132634. https:\/\/doi.org\/10.1038\/npp.2012.123","DOI":"10.1038\/npp.2012.123"},{"key":"e_1_3_3_78_1","doi-asserted-by":"crossref","unstructured":"Rubino E et al. 2025. Exome sequencing reveals a rare damaging variant in GRIN2C in familial late-onset alzheimer\u2019s disease. Alzheimers Res Ther. 17(1):21. https:\/\/doi.org\/10.1186\/s13195-024-01661-y","DOI":"10.1186\/s13195-024-01661-y"},{"key":"e_1_3_3_79_1","doi-asserted-by":"crossref","unstructured":"Salimando GJ Hyun M Boyt KM Winder DG. 2020. BNST GluN2D-containing NMDA receptors influence anxiety- and depressive-like behaviors and modulate cell-specific excitatory\/inhibitory synaptic balance. J Neurosci. 40(20):3949\u20133968. https:\/\/doi.org\/10.1523\/JNEUROSCI.0270-20.2020","DOI":"10.1523\/JNEUROSCI.0270-20.2020"},{"key":"e_1_3_3_80_1","doi-asserted-by":"crossref","unstructured":"Salmi M et al. 2019. Impaired vocal communication sleep-related discharges and transient alteration of slow-wave sleep in developing mice lacking the GluN2A subunit of N-methyl-d-aspartate receptors. Epilepsia. 60(7):1424\u20131437. https:\/\/doi.org\/10.1111\/epi.16060","DOI":"10.1111\/epi.16060"},{"key":"e_1_3_3_81_1","doi-asserted-by":"crossref","unstructured":"Sang CN Booher S Gilron I Parada S Max MB. 2002. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology. 96(5):1053\u20131061. https:\/\/doi.org\/10.1097\/00000542-200205000-00005","DOI":"10.1097\/00000542-200205000-00005"},{"key":"e_1_3_3_82_1","doi-asserted-by":"crossref","unstructured":"Saran T et al. 2021. Effect of 4-week physical exercises on tryptophan kynurenine and kynurenic acid content in human sweat. Sci Rep. 11(1):11092. https:\/\/doi.org\/10.1038\/s41598-021-90616-6","DOI":"10.1038\/s41598-021-90616-6"},{"key":"e_1_3_3_83_1","doi-asserted-by":"crossref","unstructured":"Seminowicz DA et al. 2013. Cognitive-behavioral therapy increases prefrontal cortex gray matter in patients with chronic pain. J Pain. 14(12):1573\u20131584. https:\/\/doi.org\/10.1016\/j.jpain.2013.07.020","DOI":"10.1016\/j.jpain.2013.07.020"},{"key":"e_1_3_3_84_1","doi-asserted-by":"crossref","unstructured":"Sengar AS et al. 2019. Control of long-term synaptic potentiation and learning by alternative splicing of the NMDA receptor subunit GluN1. Cell Rep. 29(13):4285\u20134294 e4285. https:\/\/doi.org\/10.1016\/j.celrep.2019.11.087","DOI":"10.1016\/j.celrep.2019.11.087"},{"key":"e_1_3_3_85_1","doi-asserted-by":"crossref","unstructured":"Shin H-J Na H-S Do S-H. 2020. Magnesium and pain. Nutrients. 12(8):2184. https:\/\/doi.org\/10.3390\/nu12082184","DOI":"10.3390\/nu12082184"},{"key":"e_1_3_3_86_1","doi-asserted-by":"crossref","unstructured":"Singh V Shteamer J Lowe J Callaway M. 2020. Central sensitization and its role in chronic pain: what can ketamine do? Indian Journal of Pain. 34(1):3\u20137. https:\/\/doi.org\/10.4103\/ijpn.ijpn_25_20","DOI":"10.4103\/ijpn.ijpn_25_20"},{"key":"e_1_3_3_87_1","doi-asserted-by":"crossref","unstructured":"Skrenkova K et al. 2019. Structural features in the glycine-binding sites of the GluN1 and GluN3A subunits regulate the surface delivery of NMDA receptors. Sci Rep. 9(1):12303. https:\/\/doi.org\/10.1038\/s41598-019-48845-3","DOI":"10.1038\/s41598-019-48845-3"},{"key":"e_1_3_3_88_1","doi-asserted-by":"crossref","unstructured":"Soleimanpour H Imani F Dolati S Soleimanpour M Shahsavarinia K. 2022. Management of pain using magnesium sulphate: a narrative review. Postgrad Med. 134(3):260\u2013266. https:\/\/doi.org\/10.1080\/00325481.2022.2035092","DOI":"10.1080\/00325481.2022.2035092"},{"key":"e_1_3_3_89_1","first-page":"457","volume-title":"itors. Handbook of behavioral neuroscience. Elsevier","author":"Sommer C","year":"2010","unstructured":"Sommer C. 2010. Serotonin in pain and pain control. In M\u00fcller CP, Jacobs BL, editors. Handbook of behavioral neuroscience. Elsevier. Vol 21, p 457\u2013471."},{"key":"e_1_3_3_90_1","doi-asserted-by":"crossref","unstructured":"Su C et al. 2025. Glucocorticoid receptor signaling in the brain and its involvement in cognitive function. Neural Regen Res. 20(9):2520\u20132537. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-00355","DOI":"10.4103\/NRR.NRR-D-24-00355"},{"key":"e_1_3_3_91_1","doi-asserted-by":"crossref","unstructured":"Tadijan A et al. 2022. Intracellular molecular targets and signaling pathways involved in antioxidative and neuroprotective effects of cannabinoids in neurodegenerative conditions. Antioxidants (Basel). 11(10):2049. https:\/\/doi.org\/10.3390\/antiox11102049","DOI":"10.3390\/antiox11102049"},{"key":"e_1_3_3_92_1","doi-asserted-by":"crossref","unstructured":"Taylor CP Traynelis SF Siffert J Pope LE Matsumoto RR. 2016. Pharmacology of dextromethorphan: relevance to dextromethorphan\/quinidine (Nuedexta) clinical use. Pharmacol Ther. 164:170\u2013182. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.04.010","DOI":"10.1016\/j.pharmthera.2016.04.010"},{"key":"e_1_3_3_93_1","doi-asserted-by":"crossref","unstructured":"Thouaye M Yalcin I. 2023. Neuropathic pain: from actual pharmacological treatments to new therapeutic horizons. Pharmacol Ther. 251:108546. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108546","DOI":"10.1016\/j.pharmthera.2023.108546"},{"key":"e_1_3_3_94_1","doi-asserted-by":"crossref","unstructured":"Topolski MA et al. 2025. Input-specific localization of NMDA receptor GluN2 subunits in thalamocortical neurons. J Neurochem. 169(3):e70049. https:\/\/doi.org\/10.1111\/jnc.70049","DOI":"10.1111\/jnc.70049"},{"key":"e_1_3_3_95_1","doi-asserted-by":"crossref","unstructured":"Traynelis SF et al. 2010. Glutamate receptor ion channels: structure regulation and function. Pharmacol Rev. 62(3):405\u2013496. https:\/\/doi.org\/10.1124\/pr.109.002451","DOI":"10.1124\/pr.109.002451"},{"key":"e_1_3_3_96_1","doi-asserted-by":"crossref","unstructured":"Tumdam R Hussein Y Garin-Shkolnik T Stern S. 2024. NMDA receptors in neurodevelopmental disorders: pathophysiology and disease models. Int J Mol Sci. 25(22):12366. https:\/\/doi.org\/10.3390\/ijms252212366","DOI":"10.3390\/ijms252212366"},{"key":"e_1_3_3_97_1","doi-asserted-by":"crossref","unstructured":"Vekhova KA Namiot ED Jonsson J Schioth HB. 2025. Ketamine and esketamine in clinical trials: FDA-approved and emerging indications trial trends with putative mechanistic explanations. Clin Pharmacol Ther. 117(2):374\u2013386. https:\/\/doi.org\/10.1002\/cpt.3478","DOI":"10.1002\/cpt.3478"},{"key":"e_1_3_3_98_1","doi-asserted-by":"crossref","unstructured":"Vieira M Yong XLH Roche KW Anggono V. 2020. Regulation of NMDA glutamate receptor functions by the GluN2 subunits. J Neurochem. 154(2):121\u2013143. https:\/\/doi.org\/10.1111\/jnc.14970","DOI":"10.1111\/jnc.14970"},{"key":"e_1_3_3_99_1","doi-asserted-by":"crossref","unstructured":"Wen Y et al. 2022. Glutamate and GABA(A) receptor crosstalk mediates homeostatic regulation of neuronal excitation in the mammalian brain. Signal Transduct Target Ther. 7(1):340. https:\/\/doi.org\/10.1038\/s41392-022-01148-y","DOI":"10.1038\/s41392-022-01148-y"},{"key":"e_1_3_3_100_1","doi-asserted-by":"crossref","unstructured":"Witkin JM et al. 2024. AMPA receptors play an important role in the biological consequences of spinal cord injury: implications for AMPA receptor modulators for therapeutic benefit. Biochem Pharmacol. 228:116302. https:\/\/doi.org\/10.1016\/j.bcp.2024.116302","DOI":"10.1016\/j.bcp.2024.116302"},{"key":"e_1_3_3_101_1","doi-asserted-by":"crossref","unstructured":"Xie RG et al. 2022. Presynaptic NMDARs on spinal nociceptor terminals state-dependently modulate synaptic transmission and pain. Nat Commun. 13(1):728. https:\/\/doi.org\/10.1038\/s41467-022-28429-y","DOI":"10.1038\/s41467-022-28429-y"},{"key":"e_1_3_3_102_1","doi-asserted-by":"crossref","unstructured":"Xie RG Xu GY Wu SX Luo C. 2023. Presynaptic glutamate receptors in nociception. Pharmacol Ther. 251:108539. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108539","DOI":"10.1016\/j.pharmthera.2023.108539"},{"key":"e_1_3_3_103_1","doi-asserted-by":"crossref","unstructured":"Xu Z et al. 2024. rTMS and TENS relieve neuropathic pain in CCI model rats by modulating central nervous system TRPV1 and neuroinflammation. Mediators Inflamm. 2024:8500317. https:\/\/doi.org\/10.1155\/mi\/8500317","DOI":"10.1155\/mi\/8500317"},{"key":"e_1_3_3_104_1","doi-asserted-by":"crossref","unstructured":"Yamamoto S et al. 2025. The role of NMDA and NK1 receptor signaling in spine surgery-induced central sensitization. Spine (Phila Pa 1976). 50(16):1120\u20131126. https:\/\/doi.org\/10.1097\/BRS.0000000000005382","DOI":"10.1097\/BRS.0000000000005382"},{"key":"e_1_3_3_105_1","doi-asserted-by":"crossref","unstructured":"Yang L et al. 2023. Rabphilin-3A undergoes phase separation to regulate GluN2A mobility and surface clustering. Nat Commun. 14(1):379. https:\/\/doi.org\/10.1038\/s41467-023-36046-6","DOI":"10.1038\/s41467-023-36046-6"},{"key":"e_1_3_3_106_1","doi-asserted-by":"crossref","unstructured":"Yang PP et al. 2015. Effects of dextromethorphan and oxycodone on treatment of neuropathic pain in mice. J Biomed Sci. 22(1):81. https:\/\/doi.org\/10.1186\/s12929-015-0186-3","DOI":"10.1186\/s12929-015-0186-3"},{"key":"e_1_3_3_107_1","doi-asserted-by":"crossref","unstructured":"Yong XLH et al. 2021. Regulation of NMDA receptor trafficking and gating by activity-dependent CaMKIIalpha phosphorylation of the GluN2A subunit. Cell Rep. 36(1):109338. https:\/\/doi.org\/10.1016\/j.celrep.2021.109338","DOI":"10.1016\/j.celrep.2021.109338"},{"key":"e_1_3_3_108_1","doi-asserted-by":"crossref","unstructured":"Yu SP et al. 2022. Deficiency of NMDA receptor subunit GluN3A as a pathogenic factor for endogenous amyloid deposition and sporadic Alzheimer\u2019s disease. Alzheimers Dement. 18(S4):e067285. https:\/\/doi.org\/10.1002\/alz.067285","DOI":"10.1002\/alz.067285"},{"key":"e_1_3_3_109_1","doi-asserted-by":"crossref","unstructured":"Yuen EY et al. 2005. Serotonin HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism. J Neurosci. 25(23):5488. https:\/\/doi.org\/10.1523\/JNEUROSCI.1187-05.2005","DOI":"10.1523\/JNEUROSCI.1187-05.2005"},{"key":"e_1_3_3_110_1","doi-asserted-by":"crossref","unstructured":"Zhang M et al. 2023. Dysfunction of GluN3A subunit is involved in depression-like behaviors through synaptic deficits. J Affect Disord. 332:72\u201382. https:\/\/doi.org\/10.1016\/j.jad.2023.03.076","DOI":"10.1016\/j.jad.2023.03.076"},{"key":"e_1_3_3_111_1","doi-asserted-by":"crossref","unstructured":"Zhang YY et al. 2025. Activation of NR2A-Wnt-TLR2 signaling axis in satellite glial cells of the dorsal root ganglion contributes to neuropathic pain induced by nerve injury in diabetic mice. Mol Neurobiol. 62(6):8013\u20138037. https:\/\/doi.org\/10.1007\/s12035-025-04754-3","DOI":"10.1007\/s12035-025-04754-3"},{"key":"e_1_3_3_112_1","doi-asserted-by":"crossref","unstructured":"Zhao J et al. 2022. Kynurenine-3-monooxygenase (KMO) broadly inhibits viral infections via triggering NMDAR\/Ca2+ influx and CaMKII\/ IRF3-mediated IFN-beta production. PLoS Pathog. 18(3):e1010366. https:\/\/doi.org\/10.1371\/journal.ppat.1010366","DOI":"10.1371\/journal.ppat.1010366"},{"key":"e_1_3_3_113_1","doi-asserted-by":"crossref","unstructured":"Zhao L Du M Zhang R. 2024. The improvement effect of exercise on rats with chronic stress-induced depression-like behavior: a discussion based on the kynurenine pathway. J Int Med Res. 52(7):3000605241261986. https:\/\/doi.org\/10.1177\/03000605241261986","DOI":"10.1177\/03000605241261986"},{"key":"e_1_3_3_114_1","doi-asserted-by":"crossref","unstructured":"Zheng YN Zheng YL Wang XQ Chen PJ. 2024. Role of exercise on inflammation cytokines of neuropathic pain in animal models. Mol Neurobiol. 61(12):10288\u201310301. https:\/\/doi.org\/10.1007\/s12035-024-04214-4","DOI":"10.1007\/s12035-024-04214-4"},{"key":"e_1_3_3_115_1","doi-asserted-by":"crossref","unstructured":"Zhou J et al. 2025. Resolving native GABA(A) receptor structures from the human brain. Nature. 638(8050):562\u2013568. https:\/\/doi.org\/10.1038\/s41586-024-08454-1","DOI":"10.1038\/s41586-024-08454-1"},{"key":"e_1_3_3_116_1","doi-asserted-by":"crossref","unstructured":"Zhu CC Zheng YL Gong C Chen BL Guo JB. 2025. Role of exercise on neuropathic pain in preclinical models: perspectives for neuroglia. Mol Neurobiol. 62(3):3684\u20133696. https:\/\/doi.org\/10.1007\/s12035-024-04511-y","DOI":"10.1007\/s12035-024-04511-y"},{"key":"e_1_3_3_117_1","doi-asserted-by":"crossref","unstructured":"Zhuo M. 2024. Long-term plasticity of NMDA GluN2B (NR2B) receptor in anterior cingulate cortical synapses. Mol Pain. 20:17448069241230258. https:\/\/doi.org\/10.1177\/17448069241230258","DOI":"10.1177\/17448069241230258"},{"key":"e_1_3_3_118_1","doi-asserted-by":"crossref","unstructured":"Zweckstetter M Dityatev A Ponimaskin E. 2021. Structure of serotonin receptors: molecular underpinning of receptor activation and modulation. Signal Transduct Target Ther. 6(1):243. https:\/\/doi.org\/10.1038\/s41392-021-00668-3","DOI":"10.1038\/s41392-021-00668-3"}],"container-title":["The Neuroscientist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10738584251410528","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10738584251410528","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10738584251410528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:09:39Z","timestamp":1777684179000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10738584251410528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":117,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1177\/10738584251410528"],"URL":"https:\/\/doi.org\/10.1177\/10738584251410528","relation":{},"ISSN":["1073-8584","1089-4098"],"issn-type":[{"value":"1073-8584","type":"print"},{"value":"1089-4098","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]}}}